4′-Demethyl-epipodophyllotoxin-β-d-thenylidene glucoside (VM-26)—A brief review
- 31 July 1973
- journal article
- clinical trial
- Published by Elsevier in European Journal of Cancer (1965)
- Vol. 9 (7), 477-482
- https://doi.org/10.1016/0014-2964(73)90130-8
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- Clinical Screening of Epipodophyllotoxin VM26 in Malignant Lymphomas and Solid TumoursBMJ, 1972
- Mitosis-inhibiting natural products. 24. Synthesis and antimitotic activity of glycosidic lignan derivatives related to podophyllotoxinJournal of Medicinal Chemistry, 1971
- 4′-Demethyl-epipodophyllotoxin thenylidene glucoside (VM 26), a podophyllum compound with a new mechanism of actionEuropean Journal of Cancer (1965), 1970
- Human anticancer effect of podophyllum derivatives (SPG and SPI): a preliminary report.British Journal of Cancer, 1967
- The Similarity of the Effect of Podophyllin and Colchicine and Their Use in the Treatment of Condylomata AcuminataScience, 1946